
A comprehensive review of patients receiving pembrolizumab has found an incidence of abnormal thyroid function tests as high as 15%.

Your AI-Trained Oncology Knowledge Connection!


Published: October 21st 2015 | Updated:

Published: October 23rd 2015 | Updated: